Geode Capital Management, LLC Crispr Therapeutics Ag Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,008,214 shares of CRSP stock, worth $39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,008,214

Previous 973,018 3.62%

Holding current value

$39 Million

Previous $52.6 Million 9.85%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$44.62 - $62.75 $1.57 Million - $2.21 Million	35,196 Added 3.62%	1,008,214 $47.4 Million
Q2 2024 Aug 09, 2024	BUY	$51.17 - $68.18 $3.26 Million - $4.34 Million	63,720 Added 7.01%	973,018 $52.6 Million
Q1 2024 May 13, 2024	BUY	$60.67 - $89.12 $1.55 Million - $2.28 Million	25,569 Added 2.89%	909,298 $62 Million
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $1.31 Million - $2.44 Million	33,791 Added 3.98%	883,729 $55.3 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $695,874 - $904,529	15,331 Added 1.84%	849,938 $38.6 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $1.07 Million - $1.67 Million	24,623 Added 3.04%	834,607 $46.9 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $856,326 - $1.17 Million	20,886 Added 2.65%	809,984 $36.6 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $957,098 - $1.6 Million	24,422 Added 3.19%	789,098 $32.1 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $3.08 Million - $4.23 Million	50,481 Added 7.07%	764,676 $50 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $2.21 Million - $3.77 Million	51,106 Added 7.71%	714,195 $43.4 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $31.7 Million - $47.3 Million	596,823 Added 900.65%	663,089 $41.6 Million
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $126,932 - $201,546	1,811 Added 2.81%	66,266 $5.02 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $66,120 - $93,983	600 Added 0.94%	64,455 $7.21 Million
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $18,252 - $29,302	-181 Reduced 0.28%	63,855 $10.3 Million
Q1 2021 May 12, 2021	BUY	$110.72 - $210.04 $1.28 Million - $2.42 Million	11,536 Added 21.97%	64,036 $7.8 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $100,543 - $218,616	1,262 Added 2.46%	52,500 $8.04 Million
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $301,361 - $386,356	3,839 Added 8.1%	51,238 $4.29 Million
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $171,286 - $338,346	4,449 Added 10.36%	47,399 $3.48 Million
Q1 2020 May 14, 2020	BUY	$33.68 - $62.53 $125,154 - $232,361	3,716 Added 9.47%	42,950 $1.82 Million
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $27,803 - $55,432	758 Added 1.97%	39,234 $2.39 Million
Q3 2019 Nov 12, 2019	SELL	$40.99 - $52.56 $9,181 - $11,773	-224 Reduced 0.58%	38,476 $1.58 Million
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $3,970 - $5,398	112 Added 0.29%	38,700 $1.82 Million
Q1 2019 May 14, 2019	BUY	$28.02 - $40.87 $101,292 - $147,745	3,615 Added 10.34%	38,588 $1.38 Million
Q4 2018 Feb 13, 2019	SELL	$22.73 - $42.34 $19,365 - $36,073	-852 Reduced 2.38%	34,973 $999,000
Q3 2018 Nov 13, 2018	BUY	$44.35 - $65.71 $14,635 - $21,684	330 Added 0.93%	35,825 $1.59 Million
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $340,192 - $587,395	7,982 Added 29.01%	35,495 $2.09 Million
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $12,348 - $30,539	525 Added 1.95%	27,513 $1.26 Million
Q4 2017 Feb 13, 2018	BUY	$16.95 - $23.48 $9,661 - $13,383	570 Added 2.16%	26,988 $633,000
Q3 2017 Nov 14, 2017	BUY	$16.75 - $20.66 $134,536 - $165,941	8,032 Added 43.69%	26,418 $472,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,386	18,386 $294,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.02B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Crispr Therapeutics Ag Transaction History